Continuous Glucose Monitor Market Remains In Abbott’s Sights
This article was originally published in The Gray Sheet
Executive Summary
Abbott says an FDA inspection of one third-party supplier is the only remaining barrier to PMA approval for its long-delayed Freestyle Navigator continuous glucose monitor